United States Biotechnology & Medical Research

Mineralys Therapeutics Inc (MLYS)

Track

Mineralys Therapeutics Inc. experienced 36 insider trading transactions over the past 90 days, totaling approximately $14.28 million in sales. Key executives, including the Chief Medical Officer and CEO, executed these planned divestments. This activity follows a recent earnings report that missed expectations, while the stock price has declined 4.7% during this period.
Ticker: MLYS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mineralys Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
388.11
Quantity 30,334
Value US$4,429,903
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
339.45
Quantity 56,097 -16.1%
Value US$1,358,347
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
89.84
Quantity 88,261
Value US$848,199
3.1
Warren Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
26.87
Quantity 7,438 -16.2%
Value US$199,885
3.1
Warren Eric Officer Officer
Transaction date
Proposed sale
Price
26.87
Quantity 7,438
Value US$199,885
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.53
Quantity 416 -0.8%
Value US$11,036
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.48
Quantity 416
Value US$11,016
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.61
Quantity 6,349 -11.0%
Value US$168,955
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.61
Quantity 6,349
Value US$168,955
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.24
Quantity 10,700 -1.7%
Value US$291,441
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.58
Quantity 14,058 -19.6%
Value US$387,717
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.58
Quantity 14,058
Value US$387,717
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.58
Quantity 14,058
Value US$387,717
3.5
Congleton Jon Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.24
Quantity 10,700
Value US$291,441
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.72
Quantity 14,508
Value US$387,717
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.30
Quantity 2,171 -3.6%
Value US$65,781
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
30.30
Quantity 2,171
Value US$65,781
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.82
Quantity 17,000 -2.7%
Value US$455,896
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
25.94
Quantity 58,000 -8.4%
Value US$1,504,706
3.5
Congleton Jon Officer Officer
Transaction date
Proposed sale
Price
26.14
Quantity 75,000
Value US$1,960,602
3.1
Warren Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
25.90
Quantity 104,124 -73.1%
Value US$2,696,322
3.1
Warren Eric Officer Officer
Transaction date
Proposed sale
Price
25.90
Quantity 104,124
Value US$2,696,322
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -32.6%
Value US$75,000
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 4,584 -7.4%
Value US$114,600
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 4,584
Value US$114,600
3.3
Karydas Daphne Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 3,000
Value US$75,000
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
23.81
Quantity 9,890 -14.8%
Value US$235,487
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
23.81
Quantity 9,890
Value US$235,487
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
23.93
Quantity 6,349 -9.1%
Value US$151,901
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
23.93
Quantity 6,349
Value US$151,901
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
23.93
Quantity 6,349
Value US$151,901
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 2,170 -3.3%
Value US$54,250
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 2,170
Value US$54,250
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.55
Quantity 417 -0.7%
Value US$11,488
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.55
Quantity 417
Value US$11,488
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.55
Quantity 417
Value US$11,488
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.58
Quantity 14,056 -18.1%
Value US$401,789
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
28.58
Quantity 14,056
Value US$401,790
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.36
Quantity 6,348 -8.3%
Value US$186,348
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
29.36
Quantity 6,348
Value US$186,348
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.71
Quantity 2,171 -3.0%
Value US$64,500
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
29.71
Quantity 2,171
Value US$64,500
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
31.33
Quantity 416 -0.6%
Value US$13,033
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
31.33
Quantity 416
Value US$13,033
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.66
Quantity 6,348 -8.3%
Value US$175,586
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.66
Quantity 6,348
Value US$175,586
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.54
Quantity 14,058 -15.6%
Value US$373,087
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.83
Quantity 15,730 -2.2%
Value US$421,979
3.5
Congleton Jon Officer Officer
Transaction date
Proposed sale
Price
26.83
Quantity 15,730
Value US$421,980
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.54
Quantity 14,058
Value US$373,087
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.38
Quantity 2,170 -2.8%
Value US$59,415
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.38
Quantity 2,170
Value US$59,415
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -32.6%
Value US$75,000
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -32.6%
Value US$75,000
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.05
Quantity 453 -0.1%
Value US$12,254
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.54
Quantity 55,183 -7.3%
Value US$1,464,474
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
25.50
Quantity 19,364 -2.5%
Value US$493,794
3.5
Congleton Jon Officer Officer
Transaction date
Proposed sale
Price
26.27
Quantity 75,000
Value US$1,970,521
3.3
Karydas Daphne Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 3,000
Value US$75,000
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
25.65
Quantity 417
Value US$10,696
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.65
Quantity 417 -0.5%
Value US$10,696
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.82
Quantity 253 -0.3%
Value US$7,038
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.37
Quantity 3,079 -3.9%
Value US$84,265
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.91
Quantity 10,726 -11.9%
Value US$277,922
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.26
Quantity 14,058
Value US$369,225
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.37
Quantity 6,348 -7.1%
Value US$173,748
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.37
Quantity 6,348
Value US$173,748
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.84
Quantity 2,171 -2.6%
Value US$58,270
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.84
Quantity 2,171
Value US$58,270
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.59
Quantity 417 -0.9%
Value US$11,505
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.59
Quantity 417
Value US$11,505
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.58
Quantity 6,348 -12.6%
Value US$175,100
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.33
Quantity 4,166 -7.6%
Value US$113,857
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
30,334
388.11
US$4,429,903 		30,334 388.11 US$4,429,903
2026-08-12 2026-08-10 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
56,097 -16.1%
339.45
US$1,358,347 		56,097 -16.1% 339.45 US$1,358,347
2026-08-10 2026-08-10 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
88,261
89.84
US$848,199 		88,261 89.84 US$848,199
2026-07-23 2026-07-21 PlS Planned sale
3.1
Warren Eric

Chief Commercial Officer

Officer
7,438 -16.2%
26.87
US$199,885 		7,438 -16.2% 26.87 US$199,885
2026-07-21 2026-07-21 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
7,438
26.87
US$199,885 		7,438 26.87 US$199,885
2026-07-20 2026-07-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
416 -0.8%
26.53
US$11,036 		416 -0.8% 26.53 US$11,036
2026-07-17 2026-07-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
416
26.48
US$11,016 		416 26.48 US$11,016
2026-07-15 2026-07-15 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,349 -11.0%
26.61
US$168,955 		6,349 -11.0% 26.61 US$168,955
2026-07-15 2026-07-15 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,349
26.61
US$168,955 		6,349 26.61 US$168,955
2026-07-15 2026-07-13 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
10,700 -1.7%
27.24
US$291,441 		10,700 -1.7% 27.24 US$291,441
2026-07-15 2026-07-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
14,058 -19.6%
27.58
US$387,717 		14,058 -19.6% 27.58 US$387,717
2026-07-14 2026-07-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
27.58
US$387,717 		14,058 27.58 US$387,717
2026-07-14 2026-07-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
27.58
US$387,717 		14,058 27.58 US$387,717
2026-07-13 2026-07-13 PrS Proposed sale
3.5
Congleton Jon

Officer; Director

Executive Director
10,700
27.24
US$291,441 		10,700 27.24 US$291,441
2026-07-13 2026-07-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,508
26.72
US$387,717 		14,508 26.72 US$387,717
2026-07-10 2026-07-09 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,171 -3.6%
30.30
US$65,781 		2,171 -3.6% 30.30 US$65,781
2026-07-09 2026-07-09 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,171
30.30
US$65,781 		2,171 30.30 US$65,781
2026-06-30 2026-06-30 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
17,000 -2.7%
26.82
US$455,896 		17,000 -2.7% 26.82 US$455,896
2026-06-30 2026-06-30 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
58,000 -8.4%
25.94
US$1,504,706 		58,000 -8.4% 25.94 US$1,504,706
2026-06-30 2026-06-30 PrS Proposed sale
3.5
Congleton Jon

Officer

Officer
75,000
26.14
US$1,960,602 		75,000 26.14 US$1,960,602
2026-06-30 2026-06-26 PlS Planned sale
3.1
Warren Eric

Chief Commercial Officer

Officer
104,124 -73.1%
25.90
US$2,696,322 		104,124 -73.1% 25.90 US$2,696,322
2026-06-29 2026-06-26 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
104,124
25.90
US$2,696,322 		104,124 25.90 US$2,696,322
2026-06-17 2026-06-17 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-06-17 2026-06-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
4,584 -7.4%
25.00
US$114,600 		4,584 -7.4% 25.00 US$114,600
2026-06-17 2026-06-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
4,584
25.00
US$114,600 		4,584 25.00 US$114,600
2026-06-17 2026-06-17 PrS Proposed sale
3.3
Karydas Daphne

Officer

Officer
3,000
25.00
US$75,000 		3,000 25.00 US$75,000
2026-06-17 2026-06-15 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
9,890 -14.8%
23.81
US$235,487 		9,890 -14.8% 23.81 US$235,487
2026-06-15 2026-06-15 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
9,890
23.81
US$235,487 		9,890 23.81 US$235,487
2026-06-12 2026-06-12 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,349 -9.1%
23.93
US$151,901 		6,349 -9.1% 23.93 US$151,901
2026-06-12 2026-06-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,349
23.93
US$151,901 		6,349 23.93 US$151,901
2026-06-12 2026-06-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,349
23.93
US$151,901 		6,349 23.93 US$151,901
2026-06-12 2026-06-10 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,170 -3.3%
25.00
US$54,250 		2,170 -3.3% 25.00 US$54,250
2026-06-10 2026-06-10 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,170
25.00
US$54,250 		2,170 25.00 US$54,250
2026-05-19 2026-05-18 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
417 -0.7%
27.55
US$11,488 		417 -0.7% 27.55 US$11,488
2026-05-18 2026-05-18 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
27.55
US$11,488 		417 27.55 US$11,488
2026-05-18 2026-05-18 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
27.55
US$11,488 		417 27.55 US$11,488
2026-05-13 2026-05-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
14,056 -18.1%
28.58
US$401,789 		14,056 -18.1% 28.58 US$401,789
2026-05-13 2026-05-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,056
28.58
US$401,790 		14,056 28.58 US$401,790
2026-05-13 2026-05-12 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,348 -8.3%
29.36
US$186,348 		6,348 -8.3% 29.36 US$186,348
2026-05-12 2026-05-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,348
29.36
US$186,348 		6,348 29.36 US$186,348
2026-05-13 2026-05-11 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,171 -3.0%
29.71
US$64,500 		2,171 -3.0% 29.71 US$64,500
2026-05-11 2026-05-11 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,171
29.71
US$64,500 		2,171 29.71 US$64,500
2026-04-21 2026-04-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
416 -0.6%
31.33
US$13,033 		416 -0.6% 31.33 US$13,033
2026-04-17 2026-04-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
416
31.33
US$13,033 		416 31.33 US$13,033
2026-04-15 2026-04-15 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,348 -8.3%
27.66
US$175,586 		6,348 -8.3% 27.66 US$175,586
2026-04-15 2026-04-15 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,348
27.66
US$175,586 		6,348 27.66 US$175,586
2026-04-15 2026-04-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
14,058 -15.6%
26.54
US$373,087 		14,058 -15.6% 26.54 US$373,087
2026-04-15 2026-04-13 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
15,730 -2.2%
26.83
US$421,979 		15,730 -2.2% 26.83 US$421,979
2026-04-13 2026-04-13 PrS Proposed sale
3.5
Congleton Jon

Officer

Officer
15,730
26.83
US$421,980 		15,730 26.83 US$421,980
2026-04-13 2026-04-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
26.54
US$373,087 		14,058 26.54 US$373,087
2026-04-13 2026-04-09 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,170 -2.8%
27.38
US$59,415 		2,170 -2.8% 27.38 US$59,415
2026-04-09 2026-04-09 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,170
27.38
US$59,415 		2,170 27.38 US$59,415
2026-04-02 2026-03-31 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-04-02 2026-03-31 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-04-02 2026-03-31 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
453 -0.1%
27.05
US$12,254 		453 -0.1% 27.05 US$12,254
2026-04-02 2026-03-31 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
55,183 -7.3%
26.54
US$1,464,474 		55,183 -7.3% 26.54 US$1,464,474
2026-04-02 2026-03-31 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
19,364 -2.5%
25.50
US$493,794 		19,364 -2.5% 25.50 US$493,794
2026-03-31 2026-03-31 PrS Proposed sale
3.5
Congleton Jon

Officer

Officer
75,000
26.27
US$1,970,521 		75,000 26.27 US$1,970,521
2026-03-31 2026-03-31 PrS Proposed sale
3.3
Karydas Daphne

Officer

Officer
3,000
25.00
US$75,000 		3,000 25.00 US$75,000
2026-03-31 2026-03-30 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
58,300 +1.0%
24.16
US$1,408,528 		58,300 +1.0% 24.16 US$1,408,528
2026-03-31 2026-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
310,700 +5.7%
23.67
US$7,354,269 		310,700 +5.7% 23.67 US$7,354,269
2026-03-17 2026-03-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
25.65
US$10,696 		417 25.65 US$10,696
2026-03-17 2026-03-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
417 -0.5%
25.65
US$10,696 		417 -0.5% 25.65 US$10,696
2026-03-16 2026-03-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
253 -0.3%
27.82
US$7,038 		253 -0.3% 27.82 US$7,038
2026-03-16 2026-03-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
3,079 -3.9%
27.37
US$84,265 		3,079 -3.9% 27.37 US$84,265
2026-03-16 2026-03-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
10,726 -11.9%
25.91
US$277,922 		10,726 -11.9% 25.91 US$277,922
2026-03-13 2026-03-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
26.26
US$369,225 		14,058 26.26 US$369,225
2026-03-16 2026-03-12 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,348 -7.1%
27.37
US$173,748 		6,348 -7.1% 27.37 US$173,748
2026-03-12 2026-03-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,348
27.37
US$173,748 		6,348 27.37 US$173,748
2026-03-10 2026-03-09 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,171 -2.6%
26.84
US$58,270 		2,171 -2.6% 26.84 US$58,270
2026-03-09 2026-03-09 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,171
26.84
US$58,270 		2,171 26.84 US$58,270
2026-02-17 2026-02-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
417 -0.9%
27.59
US$11,505 		417 -0.9% 27.59 US$11,505
2026-02-17 2026-02-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
27.59
US$11,505 		417 27.59 US$11,505
2026-02-13 2026-02-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,348 -12.6%
27.58
US$175,100 		6,348 -12.6% 27.58 US$175,100
2026-02-13 2026-02-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
4,166 -7.6%
27.33
US$113,857 		4,166 -7.6% 27.33 US$113,857
Explore more

More insider trading research around Mineralys Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America